These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 16502411

  • 1. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
    Hou P, Ji M, Yang B, Chen Z, Qiu J, Shi X, Lu Z.
    Cancer; 2006 Apr 01; 106(7):1602-9. PubMed ID: 16502411
    [Abstract] [Full Text] [Related]

  • 2. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 3. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y, Kitajima Y, Miyoshi A, Sato K, Kitahara K, Soejima H, Miyazaki K.
    Ann Surg Oncol; 2005 May 01; 12(5):354-63. PubMed ID: 15915369
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.
    Clin Cancer Res; 2005 Aug 01; 11(15):5365-9. PubMed ID: 16061849
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.
    Brabender J, Usadel H, Metzger R, Schneider PM, Park J, Salonga D, Tsao-Wei DD, Groshen S, Lord RV, Takebe N, Schneider S, Hölscher AH, Danenberg KD, Danenberg PV.
    Clin Cancer Res; 2003 Jan 15; 9(1):223-7. PubMed ID: 12538473
    [Abstract] [Full Text] [Related]

  • 10. Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung.
    Kim YT, Park SJ, Lee SH, Kang HJ, Hahn S, Kang CH, Sung SW, Kim JH.
    J Thorac Cardiovasc Surg; 2005 Nov 15; 130(5):1378. PubMed ID: 16256792
    [Abstract] [Full Text] [Related]

  • 11. Promoter methylation status of multiple genes in uveal melanoma.
    Merhavi E, Cohen Y, Avraham BC, Frenkel S, Chowers I, Pe'er J, Goldenberg-Cohen N.
    Invest Ophthalmol Vis Sci; 2007 Oct 15; 48(10):4403-6. PubMed ID: 17898258
    [Abstract] [Full Text] [Related]

  • 12. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT, Lee SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2005 Apr 15; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines.
    Fang MZ, Jin Z, Wang Y, Liao J, Yang GY, Wang LD, Yang CS.
    Int J Oncol; 2005 Mar 15; 26(3):615-22. PubMed ID: 15703815
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.
    Bello MJ, Alonso ME, Amiñoso C, Anselmo NP, Arjona D, Gonzalez-Gomez P, Lopez-Marin I, de Campos JM, Gutierrez M, Isla A, Kusak ME, Lassaletta L, Sarasa JL, Vaquero J, Casartelli C, Rey JA.
    Mutat Res; 2004 Oct 04; 554(1-2):23-32. PubMed ID: 15450401
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations.
    Kim JI, Suh JT, Choi KU, Kang HJ, Shin DH, Lee IS, Moon TY, Kim WT.
    Hum Pathol; 2009 Jul 04; 40(7):934-41. PubMed ID: 19356788
    [Abstract] [Full Text] [Related]

  • 19. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P, Coulibaly B, Nanni I, Fina F, Eudes N, Giorgi R, Barrie M, Chinot O, Fuentes S, Dufour H, Ouafik L, Figarella-Branger D.
    Cancer; 2009 Oct 15; 115(20):4783-94. PubMed ID: 19637364
    [Abstract] [Full Text] [Related]

  • 20. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.
    Lung Cancer; 2007 Oct 15; 58(1):131-8. PubMed ID: 17606310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.